Results 221 to 230 of about 2,739,853 (293)

Increase in serum prolactin levels as a potential biomarker in Crohn's disease: a prospective cohort study. [PDF]

Front Med (Lausanne)
Lu M, Xu M, Tang X, Qiao L, Chen H, Yang B.   +5 more
europepmc   +1 more source

MASLD: insights on the role of folate in hepatic lipid metabolism. [PDF]

Front Nutr
Yang M, Xiao X, Mei J, Pubu-Ciren, Gong Q.   +4 more
europepmc   +1 more source

Spina bifida as a multifactorial birth defect: Risk factors and genetic underpinnings. [PDF]

Pediatr Discov
Wong ES, Hu DA, Zhang L, Qi R, Xu C, Mei O, Shen G, You W, Luo C, He TC, Reid RR, Shi LS, Lee MJ, Zhu Y.   +13 more
europepmc   +1 more source

Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists

Reproductive Toxicology, 2005
Since the protective effect of folic acid (FA) on birth defects is well known, it is reasonable to assume intrauterine exposure to FA antagonists increases the risk on these defects. We have therefore performed case-control analyses to investigate the risk of intrauterine exposure to FA antagonists, using data on births from the EUROCAT Northern ...
Willemijn Meijer, Hermien de Walle, Mieke Kerstjens   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Treatment of psoriasis with folic acid antagonists.

Archives of Dermatology, 1958
Since the reporting of clinical improvement observed in the treatment of psoriasis with aminopterin, 1 our interest has been aroused to reevaluate the results obtained with this drug as well as with its close relative amethopterin. These drugs were used in our private practice in relatively low but therapeutic dosage.
W. Edmundson, W. B. Guy
semanticscholar   +3 more sources

CHROMOSOMAL ABNORMALITIES PRODUCED BY FOLIC ACID ANTAGONISTS.

British Journal of Dermatology, 1965
A SMALL series of cases has been investigated for toxic efFects following treatment with folic acid antagonists, and has been reported in this Journal (Ryan et al., 1064).
T. Ryan, M. M. Boddington, A. Spriggs
semanticscholar   +3 more sources

THE TREATMENT OF PSORIASIS WITH FOLIC ACID ANTAGONISTS. *

British Journal of Dermatology, 1964
T. J. Ryan, H. R. Vickers, S. Salem, S. T. Callender, J. Badenoch   +4 more
semanticscholar   +3 more sources

Folic acid antagonists in cancer chemotherapy.

Pharmacological Reviews, 1962
Lilian Delmonte, T. Jukes
semanticscholar   +3 more sources

Folic Acid Antagonists during Pregnancy and the Risk of Birth Defects

New England Journal of Medicine, 2000
Allen Mitchell, Martha Werler
exaly   +2 more sources

Aryl hydrocarbon receptor (AHR): towards understanding intestinal microbial ligands including vitamin B12 and folic acid as natural antagonists.

Biochemical Pharmacology, 2023
AHR has been identified as ligand-modulated transcription factor and environmental sensor. However, explanation of its multiple agonistic and antagonistic ligands is far from complete.
Karl Walter Bock
semanticscholar   +1 more source